2012 annual financial data
United Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was 35.33%.
Operating income was 421,646,000 USD and net income was 304,442,000 USD.
Operating cash flow was 323,628,000 USD.
Get free United Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 916,076,000 USD
- Operating income
- 421,646,000 USD
- Net income
- 304,442,000 USD
- Operating cash flow
- 323,628,000 USD